HERON THERAPEUTICS, INC. /DE/ (HRTX) Net margin 2016–2025
HERON THERAPEUTICS, INC. /DE/ (HRTX) net profit margin by fiscal year — reported net income divided by reported revenue.
-12.9%FY2025 · since FY2016: -13537.4% → -12.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -12.9% | -3.2 pp |
| FY2024 | -9.7% | +77.7 pp |
| FY2023 | -87.4% | +81.7 pp |
| FY2022 | -169.0% | +86.9 pp |
| FY2021 | -255.9% | +0.5 pp |
| FY2020 | -256.4% | -116.1 pp |
| FY2019 | -140.3% | +90.6 pp |
| FY2018 | -230.8% | +411.0 pp |
| FY2017 | -641.9% | +12895.5 pp |
| FY2016 | -13537.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice